Baxter International | Actif À Court Terme



Current Assets Changement Date
Abbott USD 24.47B 1.32B 2025-06
AtriCure USD 271.26M 19.77M 2025-06
Avanos Medical USD 356M 3.6M 2025-06
Baxter International USD 7.04B 1.82B 2025-03
Becton, Dickinson and Co. USD 9B 331M 2025-06
Boston Scientific USD 7.34B 415M 2025-03
Cooper Companies USD 2.13B 138.7M 2025-04
Dexcom USD 5.03B 476.4M 2025-06
Edwards Lifesciences USD 6.21B 72.7M 2025-03
Fresenius EUR 11.91B 462M 2025-03
Globus Medical USD 1.73B 19.79M 2025-06
Halozyme Therapeutics USD 1.12B 139.35M 2025-06
ICU Medical USD 1.18B 243.8M 2025-06
Insulet USD 2.28B 48.7M 2025-06
Integra LifeSciences USD 1.14B 35.58M 2025-06
Intuitive Surgical USD 12.47B 592.4M 2025-06
J&J USD 71.55B 15.66B 2025-03
Laboratory Of America USD 4.09B 297.5M 2025-06
Masimo USD 1.27B 85.8M 2025-06
Medtronic USD 23.81B 1.3B 2025-04
Merit Medical Systems USD 923.07M 35.56M 2025-06
Quest Diagnostics USD 2.2B 123M 2025-06
Smith & Nephew USD 4.63B 206M 2025-06
Stryker USD 13B 19M 2025-06
Tandem Diabetes Care USD 614.82M 48.62M 2025-06
Teleflex USD 1.72B 184.95M 2025-06
Terumo JPY 718.08B 5.42B 2025-06
Zimmer Biomet Holdings USD 5.05B 536.3M 2025-06


Baxter International Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.